ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn

Reuters01:43

An alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immunome IMNM.O, Prelude Therapeutics PRLD.O, Context Therapeutics CNTX.O, Relay Therapeutics RLAY.O and Oncolytics ONCY.O.

The alert has been withdrawn and there will be no substitute.

STORY_NUMBER: nTUA1LWBBS

STORY_DATE: 16/12/2025

STORY_TIME: 05:18:00 PM GMT

((bangalore.newsroom@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592939749?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 01:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592939749","market":"us","top_or_hot":-1,"title":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn</title></head><body><p>An alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immunome <span>IMNM.O</span>, Prelude <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> <span>PRLD.O</span>, Context Therapeutics <span>CNTX.O</span>, <a href=\"https://laohu8.com/S/RLAY\">Relay Therapeutics</a> <span>RLAY.O</span> and Oncolytics <span>ONCY.O</span>. </p><p>The alert has been withdrawn and there will be no substitute.</p><p>STORY_NUMBER: nTUA1LWBBS</p><p>STORY_DATE: 16/12/2025</p><p>STORY_TIME: 05:18:00 PM GMT</p><p> ((bangalore.newsroom@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-17 01:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn</title></head><body><p>An alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immunome <span>IMNM.O</span>, Prelude <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> <span>PRLD.O</span>, Context Therapeutics <span>CNTX.O</span>, <a href=\"https://laohu8.com/S/RLAY\">Relay Therapeutics</a> <span>RLAY.O</span> and Oncolytics <span>ONCY.O</span>. </p><p>The alert has been withdrawn and there will be no substitute.</p><p>STORY_NUMBER: nTUA1LWBBS</p><p>STORY_DATE: 16/12/2025</p><p>STORY_TIME: 05:18:00 PM GMT</p><p> ((bangalore.newsroom@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMNM","symbol_name":"Immunome Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA1LWBBS:1","article_id":"2592939749","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592939749","pubTimestamp":1765907029,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawnAn alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IMNM":"Immunome Inc.","BK4139":"生物科技","RLAY":"Relay Therapeutics","PRLD":"Prelude Therapeutics Inc","BK4007":"制药","CNTX":"Context Therapeutics Inc.","BK4563":"昨日强势股","ONCY":"Oncolytics Biotech Inc","BK4505":"高瓴资本持仓"},"translate_title":"Equity-Insider.com的咨询警报发布错误，已被撤回","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRLD":0.9,"IMNM":0.9,"CNTX":0.9,"ONCY":0.9,"RLAY":0.9},"content_text":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawnAn alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immunome IMNM.O, Prelude Therapeutics PRLD.O, Context Therapeutics CNTX.O, Relay Therapeutics RLAY.O and Oncolytics ONCY.O. The alert has been withdrawn and there will be no substitute.STORY_NUMBER: nTUA1LWBBSSTORY_DATE: 16/12/2025STORY_TIME: 05:18:00 PM GMT ((bangalore.newsroom@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592939749","isCrawlerRequest":true}